Dr. Tsuji received his MD and PhD from The University of Tokyo. He served his residency in Neurology at Jichi Medical School. In 1984, he moved to NIH and elucidated molecular basis of Gaucher disease. In 1987 he moved to Niigata University, Japan and was appointed as Professor of Neurology and Director at Brain Research Institute, Niigata University. In 2002, he moved to The University of Tokyo as Professor and Chair of Department of Neurology in 2002. His research focus is elucidation of molecular basis of hereditary as well as sporadic neurological diseases based on comprehensive genome analysis. In 2013, his team discovered that COQ2 gene is a susceptibility gene for multiple system atrophy (MSA), which suggested the efficacy of supplementation of a high dose CoQ10 for MSA. He has started a phase 2 clinical trial for MSA this year. Very recently his team discovered noncoding repeat expansions in benign adult familial myoclonus epilepsy (BAFME).
1981 Associate in Neurology, Jichi Medical School.
1984 Visiting Fellow, National Institutes of Health
1991 Professor and Chair, Department of Neurology, Brain research Institute, Niigata University
2001 Director, Brain Research Institute, Niigata University
2002 Professor and Chair, Department of Neurology, The University of Tokyo
2018 Professor, International University of Health and Welfare
2018 Director, Institute of Medical Genomics, International University of Health and Welfare
2018 Project Professor, Department of Molecular Neurology, The University of Tokyo
Dr. Dinsdale’s lab at San Diego State University uses next-generation sequencing to tease apart ecological and evolutionary relationships within marine, coral reef and kelp forest ecosystems. We are a multi-disciplinary team of students and researchers from around the globe.
Dr. Dinsdale helped establish one of the first university-level classes to offer hands-on experience with a pyrosequencing machine. In 2011, students of BIOL596 Ecological Metagenomics at SDSU sequenced the California sea lion genome at 12X coverage. Students applied bioinformatics and statistics techniques to analyze the resulting genomes and metagenomes.
Head of the Haseloff lab, with a history of research in plant viroids, RNA enzymes and engineering approaches to plant development. Current interests are in simple open systems for plant synthetic biology including programmable cell-free extracts.
Kevin White maps the gene networks that control development, disease, and evolution. His work combines technology development, genome science, computation and engineering. His lab focuses on discovering genetic factors that contribute to complex diseases such as cancer and neuropsychiatric disorders. Much of this work involves building genome-wide models of transcriptional networks and the cellular states they control.
White and his team have contributed to the human ENCODE project, the PsychENCODE project, the Cancer Genome Atlas, and the Genomic Data Commons. At the University of Chicago he also led the Chicago Pancreatic Cancer Initiative that seeks to use genomics and data science to develop individualized treatment plans that provide the most effective therapies for a person’s cancer while minimizing side effects.
As a leading translational scientist in the field of precision medicine, White seeks to apply new discoveries to develop practical solutions for treating human disease. Presently he is on sabbatical from University of Chicago at the precision medicine company Tempus Labs, Inc. where he is President and leads a team of over 100 scientists.
White has been honored as a National Institutes of Health Genome Scholar, a W. M. Keck Distinguished Young Investigator in Medical Sciences, and an Arnold and Mabel Beckman Young Investigator. He serves as an advisor on multiple boards including centers at Yale, Harvard and Northwestern University. He is also a member of the Board of Scientific Advisors for the National Cancer Institute.
Ludovic Orlando is a former student from the Ecole Normale Superieure of Lyon (ENS, 1996-2000), one of the top-5 French universities. First trained as a molecular biologist, he got more recently interested in computational biology and programming.
He received his PhD in molecular genetics from the University of Lyon, France in 2003, almost twenty years after the first ancient DNA molecule was ever sequenced. Trained in phylogenomics as a postdoc (CNRS EA 3781), he was rapidly appointed as a permanent Associate Professor at the prestigious ENS Lyon, where he taught and performed research between 2005 and 2010. He moved to the Centre for GeoGenetics, Natural History Museum of Denmark, Copenhagen, in April 2010 to start his own research group. He was appointed as a full Professor in Molecular Archaeology in March 2016 and started in December 2016 a five year, ERC-funded project on horse evolution.
His group develops integrative approaches in ancient DNA research, promoting the field of palaeomics by the merger of biochemistry, molecular biology, genomics and computational biology.
Ludovic has been part of several organizing and scientific boards of international meetings, including the prestigious international meeting for the Society of Molecular Biology and Evolution, the International Symposium on Biomolecular Archaeology and the International Union for Quaternary Research. He has been acting as an Academic Editor for the journal PLoS One since January 2012, for Scientific Reports since September 2016, and for Peer J since April 2017.
He is one of the four Editors-in-Chief for the journal ‘Science and Technology of Archeological Research’. He was expert member of the committee of the French National Research Agency (ANR, panel SVSE7 for Biodiversity, Evolution, Ecology and Agronomy) in 2012 and 2013, and an expert member of the Junior Committee of the ‘Institut Universitaire de France’ in 2015 and 2016.
Dr. Marlon Stoeckius is a senior research scientist in the NYGC’s technology innovation lab, a multidisciplinary research team, comprised of molecular biologists, engineers and chemists, seeking to advance a variety of next-generation sequencing techniques. His major focus is the development of experimental methods to obtain multimodal information from single cells. Prior to joining NYGC, he worked as postdoctoral researcher at Yale University studying gene expression regulation in early embryogenesis. He performed his graduate research in the lab of Nikolaus Rajewsky at the Max-Delbrueck-Center for Molecular Medicine Berlin, characterizing the oocyte-to-embryo transition in C. elegans. Being part of an international MDC-NYU PhD exchange program, he did stints of his PhD research in the lab of Fabio Piano at New York University. He received his PhD in molecular biology from the Humboldt University Berlin, and his MA in biomedical sciences from the University of Applied Sciences Bonn, Germany.